Table of Contents

1 Study Coverage

• 1.1 Methadone Hydrochloride Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Methadone Hydrochloride Market Size Growth Rate by Product
  • 1.4.2 Molecular Formula
  • 1.4.3 Type II
• 1.5 Market by End User
  • 1.5.1 Global Methadone Hydrochloride Market Size Growth Rate by End User
  • 1.5.2 Methadone Hydrochloride Tablet
  • 1.5.3 Methadone Hydrochloride Oral Solution
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Methadone Hydrochloride Market Size
  • 2.1.1 Global Methadone Hydrochloride Revenue 2014-2025
  • 2.1.2 Global Methadone Hydrochloride Sales 2014-2025
• 2.2 Methadone Hydrochloride Growth Rate by Regions
  • 2.2.1 Global Methadone Hydrochloride Sales by Regions
  • 2.2.2 Global Methadone Hydrochloride Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Methadone Hydrochloride Sales by Manufacturers
  • 3.1.1 Methadone Hydrochloride Sales by Manufacturers
  • 3.1.2 Methadone Hydrochloride Sales Market Share by Manufacturers
  • 3.1.3 Global Methadone Hydrochloride Market Concentration Ratio (CR5 and HHI)
• 3.2 Methadone Hydrochloride Revenue by Manufacturers
  • 3.2.1 Methadone Hydrochloride Revenue by Manufacturers (2014-2019)
  • 3.2.2 Methadone Hydrochloride Revenue Share by Manufacturers (2014-2019)
• 3.3 Methadone Hydrochloride Price by Manufacturers
• 3.4 Methadone Hydrochloride Manufacturing Base Distribution, Product Types
  • 3.4.1 Methadone Hydrochloride Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Methadone Hydrochloride Product Type
  • 3.4.3 Date of International Manufacturers Enter into Methadone Hydrochloride Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Methadone Hydrochloride Sales by Product
• 4.2 Global Methadone Hydrochloride Revenue by Product
• 4.3 Methadone Hydrochloride Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Methadone Hydrochloride Breakdown Data by End User

6 North America

• 6.1 North America Methadone Hydrochloride by Countries
  • 6.1.1 North America Methadone Hydrochloride Sales by Countries
  • 6.1.2 North America Methadone Hydrochloride Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Methadone Hydrochloride by Product
• 6.3 North America Methadone Hydrochloride by End User

7 Europe

• 7.1 Europe Methadone Hydrochloride by Countries
  • 7.1.1 Europe Methadone Hydrochloride Sales by Countries
  • 7.1.2 Europe Methadone Hydrochloride Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Methadone Hydrochloride by Product
• 7.3 Europe Methadone Hydrochloride by End User

8 Asia Pacific

• 8.1 Asia Pacific Methadone Hydrochloride by Countries
  • 8.1.1 Asia Pacific Methadone Hydrochloride Sales by Countries
  • 8.1.2 Asia Pacific Methadone Hydrochloride Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Methadone Hydrochloride by Product
• 8.3 Asia Pacific Methadone Hydrochloride by End User

9 Central & South America

• 9.1 Central & South America Methadone Hydrochloride by Countries
  • 9.1.1 Central & South America Methadone Hydrochloride Sales by Countries
  • 9.1.2 Central & South America Methadone Hydrochloride Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Methadone Hydrochloride by Product
• 9.3 Central & South America Methadone Hydrochloride by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Methadone Hydrochloride by Countries
  • 10.1.1 Middle East and Africa Methadone Hydrochloride Sales by Countries
  • 10.1.2 Middle East and Africa Methadone Hydrochloride Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Methadone Hydrochloride by Product
• 10.3 Middle East and Africa Methadone Hydrochloride by End User

11 Company Profiles

• 11.1 Eli Lilly
  • 11.1.1 Eli Lilly Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Eli Lilly Methadone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Eli Lilly Methadone Hydrochloride Products Offered
  • 11.1.5 Eli Lilly Recent Development
• 11.2 Sanofi
  • 11.2.1 Sanofi Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Sanofi Methadone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Sanofi Methadone Hydrochloride Products Offered
  • 11.2.5 Sanofi Recent Development
• 11.3 Roxane Laboratories
  • 11.3.1 Roxane Laboratories Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Roxane Laboratories Methadone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Roxane Laboratories Methadone Hydrochloride Products Offered
  • 11.3.5 Roxane Laboratories Recent Development
• 11.4 Mallinckrodt
  • 11.4.1 Mallinckrodt Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Mallinckrodt Methadone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Mallinckrodt Methadone Hydrochloride Products Offered
  • 11.4.5 Mallinckrodt Recent Development
• 11.5 Siegfried Ltd
  • 11.5.1 Siegfried Ltd Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Siegfried Ltd Methadone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Siegfried Ltd Methadone Hydrochloride Products Offered
  • 11.5.5 Siegfried Ltd Recent Development
• 11.6 MACFARLAN SMITH
  • 11.6.1 MACFARLAN SMITH Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 MACFARLAN SMITH Methadone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 MACFARLAN SMITH Methadone Hydrochloride Products Offered
  • 11.6.5 MACFARLAN SMITH Recent Development
• 11.7 Tianjin Central Pharma
  • 11.7.1 Tianjin Central Pharma Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Tianjin Central Pharma Methadone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Tianjin Central Pharma Methadone Hydrochloride Products Offered
  • 11.7.5 Tianjin Central Pharma Recent Development

12 Future Forecast

• 12.1 Methadone Hydrochloride Market Forecast by Regions
  • 12.1.1 Global Methadone Hydrochloride Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Methadone Hydrochloride Revenue Forecast by Regions 2019-2025
• 12.2 Methadone Hydrochloride Market Forecast by Product
  • 12.2.1 Global Methadone Hydrochloride Sales Forecast by Product 2019-2025
  • 12.2.2 Global Methadone Hydrochloride Revenue Forecast by Product 2019-2025
• 12.3 Methadone Hydrochloride Market Forecast by End User
• 12.4 North America Methadone Hydrochloride Forecast
• 12.5 Europe Methadone Hydrochloride Forecast
• 12.6 Asia Pacific Methadone Hydrochloride Forecast
• 12.7 Central & South America Methadone Hydrochloride Forecast
• 12.8 Middle East and Africa Methadone Hydrochloride Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Methadone Hydrochloride Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence.
North America is the largest supplier and consumer of Methadone Hydrochloride with a production market share of 39.7% and a consumption market share of 35.6%.
The second place is Europe, following North America with the production market share of 26% and the consumption market share of 29%. Asia is another important market of Methadone Hydrochloride, enjoying 14.9% sales market share.
Market Competition is not intense, as the players are controlled by country. Eli Lilly, Sanofi, Roxane Laboratories, and Mallinckrodt are the major players in the industry. They have formed global market channel of the industry. However, with the medicine level developing, there will be more competitors in the future.

The global Methadone Hydrochloride market is valued at 52 million US$ in 2018 and will reach 76 million US$ by the end of 2025, growing at a CAGR of 4.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Methadone Hydrochloride market based on company, product type, end user and key regions.

This report studies the global market size of Methadone Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Methadone Hydrochloride in these regions.
This research report categorizes the global Methadone Hydrochloride market by top players/brands, region, type and end user. This report also studies the global Methadone Hydrochloride market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Eli Lilly
Sanofi
Roxane Laboratories
Mallinckrodt
Siegfried Ltd
MACFARLAN SMITH
Tianjin Central Pharma

Market size by Product
Molecular Formula
Type II
Market size by End User
Methadone Hydrochloride Tablet
Methadone Hydrochloride Oral Solution
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Methadone Hydrochloride market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Methadone Hydrochloride market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Methadone Hydrochloride companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Methadone Hydrochloride submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Methadone Hydrochloride are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Methadone Hydrochloride market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.